|Bid||42.58 x 48300|
|Ask||42.60 x 51100|
|Day's Range||42.24 - 43.08|
|52 Week Range||37.95 - 51.56|
|Beta (5Y Monthly)||0.28|
|PE Ratio (TTM)||19.05|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jan 25, 2017|
|1y Target Est||47.90|
HILDEN, Germany & GERMANTOWN, Md., May 19, 2022--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its recently launched, environmentally friendlier QIAwave nucleic-acid extraction kits have received the prestigious ACT Environmental Impact Factor Label from My Green Lab, a non-profit organization dedicated to advancing sustainability in scientific research.
Investors are optimistic about QIAGEN (QGEN), owing to strong international growth and bullish guidance.
The launch of QIAstat-Dx Rise and other advancements to the QIAstat-Dx portfolio are expected to strengthen QIAGEN's (QGEN) syndromic testing solutions.